Search Results - "Huynh, E.T."

LB1691 The relationship of age and body mass index with immunotherapy response in merkel cell carcinoma: Analysis of 183 patients by Alam, R., Fan, X., Hippe, D.S., Huynh, E.T., Gong, E., Park, S., Nghiem, P.

Get full text

434 Novel management approaches for oligometastatic merkel cell carcinoma when standard systemic therapy is not an option by McClure, E., Akaike, T., Huynh, E.T., Harikrishnan, N., Lachance, K., Church, C., Pulliam, T., Nghiem, P.

Get full text

LB1690 Definitive radiotherapy for initial management of merkel cell carcinoma: Assessing a novel hypo-fractionated regimen by Menon, A., Huynh, E.T., Goff, P.H., Lachance, K., Nguyen, M.H., Iyer, J., Nagase, K., Parvathaneni, K., Nghiem, P., Parvathaneni, U.

Get full text

Efficacy of Single-Fraction Postoperative Radiotherapy in Resected, Early-Stage Merkel Cell Carcinoma with High-Risk Features by Goff, P.H., Huynh, E.T., Lachance, K., Harikrishnan, N., Cook, M., Schaub, S.K., Tseng, Y.D., Liao, J.J., Apisarnthanarax, S., Wallner, K., Nghiem, P., Parvathaneni, U.

“…Merkel cell carcinoma (MCC) is an aggressive skin cancer with a high recurrence risk. Postoperative radiotherapy (PORT) improves the local recurrence rate…”
Get full text

512 Single-fraction postoperative radiotherapy in early-stage merkel cell carcinoma (MCC): Effectiveness and reduced toxicity by Huynh, E.T., Goff, P.H., Lachance, K., Harikrishnan, N., Akaike, T., Cook, M., Schaub, S.K., Tseng, Y.D., Liao, J.J., Apisarnthanarax, S., Wallner, K., Nghiem, P., Parvathaneni, U.

Get full text

LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy by Tachiki, L., Yi, Y. Moshiri, Hippe, D.S., Zawacki, L., Gong, E., Pulliam, T., Lachance, K., Church, C., Fu, A., Remington, A.J., Huynh, E.T., Harikrishnan, N., Bierma, M., Zaba, L., Bhatia, S., Nghiem, P.

Get full text

Single Fraction Radiotherapy as Postoperative Treatment (SF-PORT) for Resected, Stage I/II Merkel Cell Carcinoma by Goff, P.H., Schaub, S.K., Lachance, K., Huynh, E.T., Harikrishnan, N., Cook, M., Tseng, Y.D., Liao, J.J., Apisarnthanarax, S., Wallner, K., Nghiem, P., Parvathaneni, U.

“…In the absence of randomized prospective data, the role of postoperative radiotherapy (PORT) for localized Merkel cell carcinoma (MCC) is controversial with…”
Get full text